FDA 510(k)

R&D Series Nova Compo-B Plus Bottle, R&D Series Nova Compo-B Plus Single Dose

N.º K: K192913 · 2021-01-19

SolicitanteImicryl Dis Malzemeleri Sanayi VE Ticaret AS

Fecha de decisión2021-01-19

Código de productoKLE

Comité asesorDE

DecisiónSubstantially Equivalent

Resumen del dispositivo

R&D Series Nova Compo-B Plus Bottle, R&D Series Nova Compo-B Plus Single Dose is the device name listed in this FDA 510(k) record. The listed applicant is Imicryl Dis Malzemeleri Sanayi VE Ticaret AS. It received FDA 510(k) clearance on 2021-01-19 under 510(k) number K192913. The device is classified under product code KLE. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

Preguntas frecuentes

What is the R&D Series Nova Compo-B Plus Bottle, R&D Series Nova Compo-B Plus Single Dose?

R&D Series Nova Compo-B Plus Bottle, R&D Series Nova Compo-B Plus Single Dose is a medical device that received FDA 510(k) clearance on 2021-01-19. The listed applicant is Imicryl Dis Malzemeleri Sanayi VE Ticaret AS. The 510(k) number is K192913.

When did R&D Series Nova Compo-B Plus Bottle, R&D Series Nova Compo-B Plus Single Dose receive FDA 510(k) clearance?

R&D Series Nova Compo-B Plus Bottle, R&D Series Nova Compo-B Plus Single Dose received FDA 510(k) clearance on 2021-01-19, under 510(k) number K192913.

Who is the listed applicant for R&D Series Nova Compo-B Plus Bottle, R&D Series Nova Compo-B Plus Single Dose?

The FDA 510(k) record lists Imicryl Dis Malzemeleri Sanayi VE Ticaret AS as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for R&D Series Nova Compo-B Plus Bottle, R&D Series Nova Compo-B Plus Single Dose?

The FDA product code for R&D Series Nova Compo-B Plus Bottle, R&D Series Nova Compo-B Plus Single Dose is KLE.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Otros registros que enlistan a Imicryl Dis Malzemeleri Sanayi VE Ticaret AS como solicitante

K213609NOVA RESIN dual cure, self adhesive resin cement K220077IMICRYL Composite, Composite Flow Materials K210473Nova Glass Cements (Nova Glass L, Nova Glass F, Nova Glass LC, Nova Glass BF, Nova Glass L Plus)K192178R&D Series Nova Compo N

Dispositivos relacionados (Código: KLE)

K262252MPa Max adhesiveDen-Mat Holdings, LLC K260485Any-EtchMediclus Co., Ltd.K260430Porcelain Etch GelBelport Company, Inc., Gingi-Pak K252450Adhese 2Ivoclar Vivadent, Inc.K260682Bond-PR™ Universal AdhesivePremier Dental Products Company K251587VITA VMLC PrimerVita Zahnfabrik H. Rauter GmbH & Co. Kg.

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.